Jim Cramer

Abbott Labs’ surprise guidance bump is a major positive for its shareholders
Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016. Revenue for the three months ended March 31 rose slightly more than 2% year over year to $9.96 billion, […]
Read More
We're buying more of this health-care company amid an overdone sell-off
Shortly after the opening bell, we will be buying 140 shares of Abbott Laboratories at roughly $112. Following the trade, Jim Cramer’s Charitable Trust will own 700 shares of ABT, increasing our weighting in the portfolio to 2.42% from 1.95%. We are buying more Abbott Laboratories into its recent weakness as we continue to believe […]
Read More
Nvidia stomps the bears. Plus, Cramer's thoughts on 2 struggling portfolio names
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets rebound as Nvidia goes green: […]
Read More
Jim Cramer defends Elon Musk's use of ketamine for depression: The CEO 'saved a lot of lives'
CNBC’s Jim Cramer said Tuesday that Elon Musk’s disclosure that he takes prescription ketamine for depression was courageous and “saved a lot of people from killing themselves.” “I defend him as much as possible because there are many people who would never be brave enough to admit they take this drug,” Cramer said on ” […]
Read More
Disney gets a win in Nelson Peltz board fight. 2 other portfolio stocks mount comebacks
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Markets bounce : Stocks kicked off […]
Read More
The 2 most significant gatherings for Wall Avenue following week could not be much more various
All 3 significant U.S. stock averages pulled again marginally for the 7 days, even though they stay near all-time highs in advance of next week’s Federal Reserve meeting. Earnings time is wrapping up with only a several S & P 500 corporations nonetheless left to report all Club names have now issued success. This reporting […]
Read More
The news hitting a portfolio health-care name actually removes an overhang on the stock
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. U.S. stocks were mixed Wednesday following Tuesday’s record high close for the S & P 500 on a rebound in the artificial intelligence momentum trade. One day later, tech was […]
Read More
Cramer states Apple stock could fall another 5% from right here. He also has no plans to offer it
We understood Apple’s China current market was not good. But a new report Tuesday reveals desire is even worse than imagined as shares tumble to fourth-month lows. But, heritage has shown that the tech large has been able to get out of these rough patches before — even if you can find even now some […]
Read More